These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 15833141

  • 1. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.
    Bühling F, Wille A, Röcken C, Wiesner O, Baier A, Meinecke I, Welte T, Pap T.
    Respir Res; 2005 Apr 17; 6(1):37. PubMed ID: 15833141
    [Abstract] [Full Text] [Related]

  • 2. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S, Vega M, Garban H, Bonavida B.
    Clin Immunol; 2006 Sep 17; 120(3):297-309. PubMed ID: 16784892
    [Abstract] [Full Text] [Related]

  • 3. Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritis.
    Machner A, Baier A, Wille A, Drynda S, Pap G, Drynda A, Mawrin C, Bühling F, Gay S, Neumann W, Pap T.
    Arthritis Res Ther; 2003 Sep 17; 5(5):R253-61. PubMed ID: 12932288
    [Abstract] [Full Text] [Related]

  • 4. Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis.
    Wynes MW, Edelman BL, Kostyk AG, Edwards MG, Coldren C, Groshong SD, Cosgrove GP, Redente EF, Bamberg A, Brown KK, Reisdorph N, Keith RC, Frankel SK, Riches DW.
    J Immunol; 2011 Jul 01; 187(1):527-37. PubMed ID: 21632719
    [Abstract] [Full Text] [Related]

  • 5. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL.
    J Lab Clin Med; 2000 Oct 01; 136(4):320-7. PubMed ID: 11039853
    [Abstract] [Full Text] [Related]

  • 6. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells.
    Jiang S, Wu MW, Sternberg P, Jones DP.
    Invest Ophthalmol Vis Sci; 2000 Mar 01; 41(3):645-55. PubMed ID: 10711676
    [Abstract] [Full Text] [Related]

  • 7. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O.
    Cell Immunol; 1997 Oct 10; 181(1):93-100. PubMed ID: 9344501
    [Abstract] [Full Text] [Related]

  • 8. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 10; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S, Abraham P, Daniel HD, Ramakrishna BS, Sridharan G.
    J Clin Virol; 2005 Sep 10; 34(1):63-70. PubMed ID: 16087126
    [Abstract] [Full Text] [Related]

  • 12. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar 10; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 13. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS).
    Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M, Martin TR.
    J Immunol; 1999 Aug 15; 163(4):2217-25. PubMed ID: 10438964
    [Abstract] [Full Text] [Related]

  • 14. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H, Narita K, Endo S.
    J Crit Care; 2001 Jun 15; 16(2):59-63. PubMed ID: 11481600
    [Abstract] [Full Text] [Related]

  • 15. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
    Erdoğan B, Uzaslan E, Budak F, Karadağ M, Ediger D, Oral B, Göral G, Ege E, Gözü O.
    Tuberk Toraks; 2005 Jun 15; 53(2):127-31. PubMed ID: 16100648
    [Abstract] [Full Text] [Related]

  • 16. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
    Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S.
    J Cancer Res Clin Oncol; 2002 Nov 15; 128(11):581-8. PubMed ID: 12458337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.
    Gerharz CD, Ramp U, Déjosez M, Mahotka C, Czarnotta B, Bretschneider U, Lorenz I, Müller M, Krammer PH, Gabbert HE.
    Lab Invest; 1999 Dec 15; 79(12):1521-34. PubMed ID: 10616203
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis.
    Moodley YP, Caterina P, Scaffidi AK, Misso NL, Papadimitriou JM, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA.
    J Pathol; 2004 Apr 15; 202(4):486-95. PubMed ID: 15095276
    [Abstract] [Full Text] [Related]

  • 20. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
    Nadal C, Maurel J, Gallego R, Castells A, Longarón R, Marmol M, Sanz S, Molina R, Martin-Richard M, Gascón P.
    Clin Cancer Res; 2005 Jul 01; 11(13):4770-4. PubMed ID: 16000573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.